Clinical Trial Update: Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating celecoxib, irinotecan, and concurrent radiotherapy in preoperative pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University of Pittsburgh | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED